Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aulos Bioscience, Inc.
H. Lee Moffitt Cancer Center and Research Institute
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
University of Washington
Memorial Sloan Kettering Cancer Center
Melanoma and Skin Cancer Trials Limited